Research

Hormonal

During the menopausal transition, the accumulation of intraabdominal fat (IAF) is associated with a deleterious shift in adipokine and inflammatory profiles, specifically characterized by increased levels of leptin, tissue plasminogen activator (tPA), serum amyloid A (SAA), and C-reactive protein (CRP), alongside a negative correlation with adiponectin.

For women undergoing menopause, monitor waist circumference and visceral fat rather than just total body weight. Even if your overall weight remains stable, the shift of fat to the abdominal area can trigger inflammatory changes (like increased CRP and leptin) that increase cardiovascular risk. Prioritize strategies that preserve or reduce visceral fat, such as resistance training and managing stress, as these hormonal shifts are a key driver of postmenopausal metabolic health.

GoodSupportsHIGH confidence
Women going through the menopausal transition have deleterious changes in inflammatory markers and adipokines that correlate with increased visceral adiposity.
Christine G. Lee et al. · The Journal of Clinical Endocrinology & Metabolism · 2009

Why this rating

Prospective paired cohort study with rigorous controls for subcutaneous fat, though observational in nature.

Source

Adipokines, Inflammation, and Visceral Adiposity across the Menopausal Transition: A Prospective Study

Christine G. Lee et al. · The Journal of Clinical Endocrinology & Metabolism · 2009

DOI 10.1210/jc.2008-0701

cohort · n=69Cited 270×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →